<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title42.html">
                                    Title 42
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/42CFR71.html">Part 71
                                </a><span>&nbsp/&nbsp<span>
                                Sec.  71.53  Requirements for importers of nonhuman primates.
                            </h3>
                            <p class="depth0"><em>(a)</em> Purpose. The purpose of this section is to prevent the  transmission of communicable disease from nonhuman primates (NHPs)  imported into the United States, or their offspring, to humans. The  regulations in this section are in addition to other regulations  promulgated by the Secretary to prevent the introduction, transmission,  and spread of communicable diseases under 42 CFR part 71, subpart A and  42 CFR part 70.</p><p class="depth0"><em>(b)</em> Scope. This section applies to any person importing a live NHP  into the United States, including existing importers, any person  applying to become a registered importer, and any person importing NHP  products.</p><p class="depth0"><em>(1)</em> Importers must make their facilities, vehicles, equipment, and  business records, including employee health records and animal health  records, used in the importation of NHPs, available to HHS/CDC for  inspection during operating business days and hours, and   at other necessary and reasonable times, to enable HHS/CDC to ascertain  compliance with the regulations in this section.</p><p class="depth0"><em>(2)</em> Nothing in this section supersedes or preempts enforcement of  emergency response requirements imposed by statutes or other  regulations.</p><p class="depth0"><em>(c)</em> Acronyms, initialisms, and definitions.</p><p class="depth0"><em>(1)</em> For the purposes of this section:</p><p class="depth0">AAALAC means the Association for Assessment and Accreditation of  Laboratory Animal Care International.</p><p class="depth0">AZA means the Association of Zoos and Aquariums.</p><p class="depth0">CITES means the Convention on International Trade in Endangered  Species.</p><p class="depth0">ELISA means enzyme-linked immunosorbent assay, a type of laboratory  test that measures antibodies or detects antigens for specific  pathogens.</p><p class="depth0">HHS/CDC means U.S. Department of Health and Human Services, Centers  for Disease Control and Prevention, or an authorized representative  acting on its behalf.</p><p class="depth0">IACUC means Institutional Animal Care and Use Committee.</p><p class="depth0">MOT means mammalian old tuberculin, a biological product used as a  diagnostic tool in the evaluation for mycobacterial (TB and related  bacteria) infections.</p><p class="depth0">NIOSH means the National Institute for Occupational Safety and  Health, Centers for Disease Control and Prevention, U.S. Department of  Health and Human Services.</p><p class="depth0">PPE means personal protective equipment, such as gloves,  respirators, and other devices used in preventing the spread of  communicable diseases.</p><p class="depth0">SOPs means standard operating procedures.</p><p class="depth0">TB means tuberculosis.</p><p class="depth0">TST means tuberculin skin test.</p><p class="depth0">USDA means United States Department of Agriculture.</p><p class="depth0"><em>(2)</em> For purposes of this section, the terms listed below shall have  the following meanings:</p><p class="depth0">Animal act means any use of NHPs, including offspring, for  entertainment in which the NHPs are trained to perform some behavior or  action and are part of a routinely scheduled show, performance, or  exhibition, open to the general public.</p><p class="depth0">Breeding colony means a facility where NHPs, including offspring,  are maintained for reproductive purposes.</p><p class="depth0">Broker means a person or organization within the United States that  acts as an official agent of an exporter of NHPs from another country,  or as an intermediary between such an exporter and an importer of NHPs.</p><p class="depth0">Cohort means a group of NHPs imported together into the United  States.</p><p class="depth0">Director means the Director of the Centers for Disease Control and  Prevention, U.S. Department of Health and Human Services, or an  authorized representative.</p><p class="depth0">Educational purpose means the use of NHPs, including offspring, in  the teaching of a defined educational program at the university level or  equivalent.</p><p class="depth0">Exhibition purposes means the use of NHPs, including offspring, as  part of a public display open to the general public during routinely  scheduled hours in a facility that meets or exceeds AZA accreditation  standards.</p><p class="depth0">Importer means any person importing, or attempting to import, a live  NHP into the United States, including an applicant to become a  registered importer. Within the meaning of this section, ``importer''  includes any person maintaining a facility or institution housing NHPs  during quarantine. Within the meaning of this section, ``importer'' also  includes the agent of any animal act, laboratory, or zoo that is subject  to or carries out responsibilities in accordance with the regulations in  this section.</p><p class="depth0">In transit means NHPs located within the United States that are not  intended for import, whether scheduled or not, as part of the movement  of those NHPs between a foreign country of departure and foreign country  of final destination.</p><p class="depth0">Lab or laboratory means a facility in the United States accredited  by AAALAC or licensed by USDA, conducting research using NHPs, having  foreign based facilities, and intending to transfer or transferring one  or more NHPs that were originally part of an institutionally approved,  ongoing protocol, from its foreign-based facility   into its United States facility for purposes related to that specific  research project.</p><p class="depth0">Licensed veterinarian means a person who has graduated from a  veterinary school accredited by the American Veterinary Medical  Association's Council on Education, or has a certificate issued by the  American Veterinary Medical Association's Education Commission for  Foreign Veterinary Graduates, or has received equivalent formal  education as determined by the HHS/CDC; and has received training and/or  experience in the care and management of nonhuman primates.</p><p class="depth0">Medical consultant means an occupational health physician,  physician's assistant, or registered nurse, who is knowledgeable about  the risks to human health associated with NHPs.</p><p class="depth0">Nonhuman primate or NHP means all nonhuman members of the Order  Primates.</p><p class="depth0">NHP product or Product means skulls, skins, bodies, blood, tissues,  or other biological samples from a nonhuman primate, including trophies,  mounts, rugs, or other display items.</p><p class="depth0">Offspring means the direct offspring of any live NHPs imported into  the United States and the descendants of any such offspring.</p><p class="depth0">Old World Nonhuman Primate means all nonhuman primates endemic to  Asia or Africa.</p><p class="depth0">Pathogen means any organism or substance capable of causing a  communicable disease.</p><p class="depth0">Permitted purpose means the use of NHPs for scientific, educational,  or exhibition purposes as defined in this section.</p><p class="depth0">Person means any individual or partnership, firm, company,  corporation, association, organization, including a not-for-profit  organization, such as a sanctuary, or other legal entity.</p><p class="depth0">Quarantine means the practice of isolating live NHPs for at least 31  days after arrival in a U.S. quarantine facility where the NHPs are  observed for evidence of infection with communicable disease, and where  measures are in place to prevent transmission of infection to humans or  NHPs within the cohort.</p><p class="depth0">Quarantine facility means a facility used by a registered importer  of NHPs for the purpose of quarantining imported NHPs.</p><p class="depth0">Quarantine room means a room in a registered import facility for  housing imported NHPs during the quarantine period.</p><p class="depth0">Scientific purposes means the use of NHPs including offspring for  research following a defined protocol and other standards for research  projects as normally conducted at the university level.</p><p class="depth0">Zoo means:</p><p class="depth0"><em>(1)</em> Within the United States, an AZA-accredited and professionally  maintained park, garden, or other place in which animals are kept for  public exhibition and viewing; or</p><p class="depth0"><em>(2)</em> Outside of the United States, a professionally maintained park,  garden, or other place in which animals are kept for public exhibition  and viewing that meets or exceeds the accrediting standards of the AZA.</p><p class="depth0">Zoonotic disease means any infectious agent or communicable disease  that is capable of being transmitted from animals (both wild and  domestic) to humans.</p><p class="depth0"><em>(d)</em> General prohibition on importing nonhuman primates. </p><p class="depth0"><em>(1)</em> A person  may not import live NHPs into the United States unless the person is  registered with HHS/CDC as a NHP importer in accordance with this  section.</p><p class="depth0"><em>(2)</em> A person may only import live NHPs into the United States for:</p><p class="depth0"><em>(i)</em> Permitted purposes, as defined under paragraph (c)(2) of this  section; or</p><p class="depth0"><em>(ii)</em> Use in breeding colonies, provided that all offspring will be  used only as replacement breeding stock or for permitted purposes.</p><p class="depth0"><em>(3)</em> A person may not accept, maintain, sell, resell, or otherwise  distribute imported NHPs (including their offspring) for use as pets, as  a hobby, or as an avocation with occasional display to the general  public.</p><p class="depth0"><em>(e)</em> Disposal of prohibited or excluded NHPs. </p><p class="depth0"><em>(1)</em> HHS/CDC may seize,  examine, isolate, quarantine, export, treat, or destroy any NHP if:</p><p class="depth0"><em>(i)</em> It is imported through a location other than an authorized port  of entry;</p><p class="depth0"><em>(ii)</em> It is imported for other than permitted purposes;</p><p class="depth0"><em>(iii)</em> It is maintained, sold, resold, or distributed for other than  permitted purpose;</p><p class="depth0"><em>(iv)</em> It is imported by a person who is not a registered importer; or</p><p class="depth0"><em>(v)</em> It is otherwise deemed to constitute a public health threat by  the Director.</p><p class="depth0"><em>(2)</em> For any NHP arriving in the United States through an  unauthorized location, for other than the permitted purposes, or by a  person who is not a registered importer, the person attempting to import  that NHP, must, as approved by the Director and at the person's own  expense, do one of the following:</p><p class="depth0"><em>(i)</em> Export or arrange for destruction of the NHP, or</p><p class="depth0"><em>(ii)</em> Donate the NHP for a scientific, educational, or exhibition  purpose after quarantine at a HHS/CDC-registered facility.</p><p class="depth0"><em>(3)</em> If the person attempting to import a NHP fails to dispose of the  NHP by one of the options described in paragraph (e)(2) of this section,  the Director will dispose of the NHP at the person's expense.</p><p class="depth0"><em>(4)</em> Pending disposal of any prohibited or excluded NHPs, the NHP  will be detained at the person's expense at a location approved by the  Director.</p><p class="depth0"><em>(f)</em> Authorized ports of entry for live NHPs. </p><p class="depth0"><em>(1)</em> An importer may  import live NHPs into the United States only through a port of entry  where a HHS/CDC quarantine station is located. The list of current HHS/ CDC quarantine stations can be found at http://www.HHS/CDC.gov/ quarantine/QuarantineStations.html.</p><p class="depth0"><em>(2)</em> In the event that the importer is unable to provide for entry at  a port where a HHS/CDC quarantine station is located, the importer may  only import live NHPs into the United States through another port of  entry if the Director provides advance written approval.</p><p class="depth0"><em>(3)</em> If prior written approval is not obtained from the Director, the  importer and excluded NHPs will be subject to the provisions of  paragraph (e) of this section.</p><p class="depth0"><em>(g)</em> Registration or renewal of importers. Before importing any live  NHP into the United States, including those that are part of an animal  act or those involved in zoo-to-zoo or laboratory-to-laboratory  transfers, an importer must register with and receive written approval  from the Director.</p><p class="depth0"><em>(1)</em> To register, or to renew a registration certificate, as an  importer, a person must submit the following documents to HHS/CDC:</p><p class="depth0"><em>(i)</em> A completed registration/application form;</p><p class="depth0"><em>(ii)</em> A completed statement of intent that describes the number and  types of NHPs intended for import during the registration period, the  intended permitted purposes for which the NHPs will be imported;</p><p class="depth0"><em>(iii)</em> Written SOPs that include all elements required in paragraphs  (h) through (n) of this section;</p><p class="depth0"><em>(iv)</em> A copy of all federal, state, or local registrations, licenses,  and/or permits; and</p><p class="depth0"><em>(v)</em> A signed, self-certification stating that the importer is in  compliance with the regulations contained in this section and agrees to  continue to comply with the regulations in this section.</p><p class="depth0"><em>(2)</em> Upon receiving the documentation required by this section, the  Director will review the application and either grant or deny the  application for registration as an importer. Applications that are  denied may be appealed under paragraph (u) of this section.</p><p class="depth0"><em>(i)</em> Before issuing a registration, the Director may inspect any  business record, facility, vehicle, or equipment to be used in importing  NHPs.</p><p class="depth0"><em>(ii)</em> Unless revoked in accordance with paragraph (t) of this  section, a registration certificate issued under this section is  effective for two years beginning from the date HHS/CDC issues the  registration certificate.</p><p class="depth0"><em>(iii)</em> An importer must apply to HHS/CDC for renewal of the  registration certificate not less than 30 days and not more than 60 days  before the existing registration expires.</p><p class="depth0"><em>(3)</em> All importers must comply with the requirements of paragraphs  (h) through (n) of this section.</p><p class="depth0"><em>(h)</em> Documentation. An importer must develop, and document compliance  with, a written policy that states imported NHPs, including their  offspring, will only be used and distributed for permitted purposes.</p><p class="depth0"><em>(1)</em> An importer must collect or create a record of the intended  purpose of importation for each imported NHP and the purpose must comply  with one of the permitted purposes. An importer must retain written  certifications demonstrating that the NHPs and their offspring will  continue to be used for permitted purposes for three years after the  distribution or transfer of the NHP.</p><p class="depth0"><em>(2)</em> An importer must retain records regarding each distribution of  imported NHPs. Each record must include the identity of any recipients,  the number and identity of each NHP in each shipment or sale, and the  dates of each shipment or sale, for three years after the distribution  or transfer of the NHP.</p><p class="depth0"><em>(3)</em> An importer must maintain these records in an organized manner,  either electronically or in a central location that is at or in close  proximity to the NHP facility to allow HHS/CDC to easily inspect the  records during HHS/CDC site visits during regular business hours or  within one hour of such visits. If records are maintained  electronically, they must be time-dated in a manner than cannot be  altered, and redundant back-up copies must be made in a manner that  protects against loss.</p><p class="depth0"><em>(4)</em> Before distributing or transferring an imported NHP, an importer  must:</p><p class="depth0"><em>(i)</em> Communicate to the recipients of NHPs, in writing, the  restrictions and definitions of permitted purposes; and</p><p class="depth0"><em>(ii)</em> Obtain written certifications from the intended recipient that  the NHPs will be used and distributed only for permitted purposes.</p><p class="depth0"><em>(i)</em> Worker protection plan and personal protective Equipment. </p><p class="depth0"><em>(1)</em> In  addition to complying with the requirements of this section, an importer  must comply with all relevant federal and state requirements relating to  occupational health and safety.</p><p class="depth0"><em>(2)</em> Importers must have a written worker protection plan for anyone  whose duties may result in exposure to NHPs, including procedures for  appropriate response measures in the event of an emergency. An importer  must adhere to the plan and SOPs and must ensure that each worker  covered under the plan also adheres to it and all pertinent SOPs.</p><p class="depth0"><em>(3)</em> An importer must contact HHS/CDC immediately by telephone, text,  or email, as specified in the importer's SOP, to report any instance of  a worker exposed to a zoonotic illness and must include instructions for  contacting HHS/CDC in its worker protection plan.</p><p class="depth0"><em>(4)</em> A worker protection plan must include the following:</p><p class="depth0"><em>(i)</em> Procedures to protect and train transport workers in how to  avoid and respond to zoonotic disease exposures associated with NHPs,  including procedures for appropriate responses in the event of a vehicle  crash or other emergency during transport;</p><p class="depth0"><em>(ii)</em> Hazard evaluation and worker communication procedures that  adhere to those in paragraph (i)(5) of this section;</p><p class="depth0"><em>(iii)</em> PPE requirements that adhere to those in paragraph (i)(6) of  this section;</p><p class="depth0"><em>(iv)</em> TB-control requirements that adhere to those in paragraph  (i)(7) of this section;</p><p class="depth0"><em>(v)</em> If applicable, SOPs that adhere to requirements relating to  macaques as described in paragraph (i)(8) of this section;</p><p class="depth0"><em>(vi)</em> An infection-prevention program, including infection-prevention  methods requiring, at a minimum, PPE and workplace practices for  preventing infection among workers whose duties may result in exposure  to NHPs and:</p><p class="depth0"><em>(A)</em> SOPs that include requirements for preventing workplace  infection from potentially contaminated needles or other sharp  instruments and that, at a minimum, prohibit workers from recapping used  needles by hand; removing needles by hand; or otherwise bending,  breaking, or manipulating used needles by hand.</p><p class="depth0"><em>(B)</em> SOPs requiring that used disposable syringes and needles,  scalpel blades, and other sharp items be placed in puncture-resistant  containers kept as close to the work site as practical and disinfected  and/or disposed of as hazardous waste.</p><p class="depth0"><em>(C)</em> SOPs requiring that removable, disposable PPE be autoclaved,  incinerated, or otherwise disposed of as biohazardous waste.  Nondisposable clothing worn in the quarantine facility must be  disinfected on site before laundering.</p><p class="depth0"><em>(D)</em> An infection-prevention program that requires NHP handlers to  cleanse   all bites, scratches, and/or mucosal surfaces or abraded skin exposed to  blood or body fluids immediately and thoroughly.</p><p class="depth0"><em>(E)</em> Infection-prevention procedures that require workers to  immediately flush their eyes with water for at least 15 minutes  following an exposure of blood or body fluids to the eye.</p><p class="depth0"><em>(vii)</em> Post-exposure procedures that provide potentially exposed  workers with direct and rapid access to a medical consultant including:</p><p class="depth0"><em>(A)</em> Procedures ensuring that exposed workers have direct and  immediate access to a medical consultant who has been previously  identified in the SOPs to HHS/CDC.</p><p class="depth0"><em>(B)</em> For potential exposures to herpes B virus, post-exposure  procedures that require the routing of diagnostic specimens to the  National B Virus Resource Center located at Georgia State University in  Atlanta, Georgia, or another location as specified by HHS/CDC.</p><p class="depth0"><em>(viii)</em> Procedures for documenting the frequency of worker training,  including for those working in the quarantine facility.</p><p class="depth0"><em>(5)</em> As part of the worker protection plan described in this  paragraph (i), an importer must establish, implement, and maintain  hazard evaluation and worker communication procedures that include the  following:</p><p class="depth0"><em>(i)</em> A description of the known zoonotic disease and injury hazards  associated with handling NHPs;</p><p class="depth0"><em>(ii)</em> The need for PPE when handling NHPs and training in proper use  of PPE, including re-training and reinforcement of appropriate use;</p><p class="depth0"><em>(iii)</em> Procedures for monitoring workers for signs of zoonotic  illness, including procedures that ensure reporting to HHS/CDC by  telephone, text, or email within 24 hours of the occurrence of illness  in any worker suspected of having a zoonotic disease; and</p><p class="depth0"><em>(iv)</em> Procedures for disinfection of garments, supplies, equipment,  and waste.</p><p class="depth0"><em>(6)</em> As part of the worker protection plan described in this  paragraph (i), an importer must identify the PPE required for each task  or working area. Additionally, in this part of the worker protection  plan, an importer must ensure the following:</p><p class="depth0"><em>(i)</em> Any required PPE must be available to workers when needed;</p><p class="depth0"><em>(ii)</em> Workers in direct contact with NHPs must wear the following:</p><p class="depth0"><em>(A)</em> Gloves of sufficient thickness to reduce the risk of cuts,  scratches, and punctures;</p><p class="depth0"><em>(B)</em> At a minimum, disposable NIOSH-approved N95 respirators, in  compliance with OSHA 29 CFR Sec.  1910.134, which requires a respiratory  protection program;</p><p class="depth0"><em>(C)</em> Face shields or eye protection; and</p><p class="depth0"><em>(D)</em> Outer protective clothing when opening crates, removing foreign  materials from crates, feeding NHPs, removing dead NHPs, or handling  bedding materials.</p><p class="depth0"><em>(iii)</em> Workers handling crates or pallets containing NHPs must wear  the following:</p><p class="depth0"><em>(A)</em> Elbow-length, reinforced leather gloves or equivalent gloves  that prevent penetration of splinters, other crating materials, or  debris;</p><p class="depth0"><em>(B)</em> Outer protective clothing;</p><p class="depth0"><em>(C)</em> Waterproof shoes or boots;</p><p class="depth0"><em>(D)</em> NIOSH-approved respiratory protection that is compliant with  OSHA regulations at 29 CFR 1910.134, and;</p><p class="depth0"><em>(E)</em> Face shields or eye protection.</p><p class="depth0"><em>(iv)</em> Workers whose faces may come within 5 feet of an NHP must wear  disposable NIOSH-approved N95 respirators and either face shields or eye  protection to protect against aerosol or droplet transmission of  pathogens;</p><p class="depth0"><em>(v)</em> Workers must remove disposable PPE and discard as a biohazard;  and</p><p class="depth0"><em>(vi)</em> Workers must not drink, eat, or smoke while physically handling  NHPs or cages, crates, or other materials from such NHPs.</p><p class="depth0"><em>(7)</em> For TB protection, an importer must ensure the following:</p><p class="depth0"><em>(i)</em> Workers in a facility housing NHPs must have a baseline  evaluation for TB prior to working with NHPs and an evaluation at least  annually;</p><p class="depth0"><em>(ii)</em> Prompt and direct access to a medical consultant who is capable  of performing the evaluation and maintaining records for such tests;</p><p class="depth0"><em>(iii)</em> If an NHP is found to have laboratory-confirmed TB, any worker  who had previously entered any room where a confirmed NHP has been  housed must   promptly undergo a post-exposure TB evaluation and</p><p class="depth0"><em>(A)</em> If that test is negative, the worker must undergo another TB  evaluation 3 months later; and</p><p class="depth0"><em>(B)</em> If either test is reactive, the worker must be referred for  medical evaluation; and</p><p class="depth0"><em>(C)</em> The HHS/CDC must be immediately notified of the results of the  medical evaluation by telephone, text, or email as specified in the  importer's SOPs.</p><p class="depth0"><em>(iv)</em> Compliance with exposure-control planning elements under 29 CFR  1910.1030 for workers who will have parenteral and other contact with  blood or other potentially infectious material from NHPs and compliance  with the respiratory protection requirements in 29 CFR 1910.134.</p><p class="depth0"><em>(8)</em> For importation of macaques, an importer must develop, implement  and adhere to a written PPE program to prevent herpes B virus  transmission. The program must be based on a thorough hazard assessment  of all work procedures, potential routes of exposure (e.g., bites,  scratches, or mucosal exposures), and potential adverse health outcomes.</p><p class="depth0"><em>(9)</em> An importer must keep records of all serious febrile illnesses  (fever greater than 101.3 degrees Fahrenheit [38.5 degrees Celsius] for  more than 48 hours) in workers having exposure to NHPs in transit or in  quarantine. The record must be kept by the importer as part of the  worker's administrative records. The importer must promptly notify HHS/ CDC by telephone, text, or email if such an illness occurs. An importer  must ensure that the medical consultant providing care is informed that  the patient works with and/or has been exposed to NHPs.</p><p class="depth0"><em>(j)</em> SOP requirements and equipment standards for crating, caging,  and transporting live nonhuman primates. Equipment standards for  crating, caging, and transporting live NHPs must be in accordance with  USDA Animal Welfare regulation standards (9 CFR parts 1, 2, and 3) and  International Air Transport Association standards, and an importer must  establish, implement, maintain, and adhere to SOPs that ensure the  following requirements are met:</p><p class="depth0"><em>(1)</em> Any crate used to transport NHPs must be free of sharp  projections that could scratch or otherwise injure workers or NHPs.</p><p class="depth0"><em>(2)</em> Glass items must not be used for feeding or watering NHPs during  transport.</p><p class="depth0"><em>(3)</em> NHPs must only be removed from crates in an approved quarantine  facility under the supervision of a licensed veterinarian.</p><p class="depth0"><em>(4)</em> NHPs must not be removed from crates during transport.</p><p class="depth0"><em>(5)</em> Upon arrival into the United States, only an importer or an  authorized representative may receive the NHPs from a conveyance (e.g.,  airplane, ship). The importer must establish an emergency contingency  plan in the unlikely event they are unable to meet the shipment.</p><p class="depth0"><em>(6)</em> All reusable items must be decontaminated between uses.</p><p class="depth0"><em>(7)</em> At all times during transport, crates containing NHPs must be  separated by a physical barrier from workers, other individuals, and all  other animals and cargo, or by a spatial barrier greater than 5 feet,  that prevents contamination of cargo or individuals with bodily fluids,  feces, or soiled bedding.</p><p class="depth0"><em>(8)</em> At all times during transport, individuals traveling with the  shipment must be protected from shared air of NHPs to prevent the  transmission of zoonotic diseases. Airflow must be unidirectional from  NHP transport workers to NHPs or, if any air is recirculated to the NHP  transport workers, it must be HEPA-filtered. If a ventilation system is  not in place, all NHP transport workers must wear respiratory  protection.</p><p class="depth0"><em>(9)</em> If traveling by plane, crates containing NHPs should be loaded  in the cargo hold last and removed first, must be placed on plastic that  prevents spillage onto the deck of the plane, and must be placed on  pallets or double crated to ensure separation from other cargo.</p><p class="depth0"><em>(10)</em> Workers, as well as NHPs, must be protected from communicable  disease exposures at any facility used en route, including  transportation holding facilities. An importer must maintain a  description of any transportation holding facilities and document the   communicable disease prevention measures taken to protect workers at  facilities used en route.</p><p class="depth0"><em>(11)</em> For each import, documentation must be made of the communicable  disease-prevention procedures to be carried out in every step of the  chain of custody, from the time of embarkation of the NHPs at the  country of origin until arrival at the quarantine facility.</p><p class="depth0"><em>(12)</em> Procedures to ensure that aircraft, ship, vehicles, and related  equipment are decontaminated following transport.</p><p class="depth0"><em>(13)</em> Used PPE, bedding, and other potentially contaminated material  must be removed from the ground transport vehicle upon arrival at the  quarantine facility and disposed of as biohazardous waste.</p><p class="depth0"><em>(k)</em> Ground transport vehicles. An importer must establish,  implement, maintain, and adhere to SOPs for ground transport vehicles  transporting NHPs that meet the following requirements.</p><p class="depth0"><em>(1)</em> Ground transport vehicles must have a separate cargo compartment  with separate heating, ventilation, and air-conditioning systems.</p><p class="depth0"><em>(2)</em> The interior surfaces of ground transport vehicle cargo  compartments must be of smooth construction, easy to clean and  disinfect.</p><p class="depth0"><em>(3)</em> Used PPE, bedding, and other potentially contaminated material  must be removed from the ground transport vehicle upon arrival at the  quarantine facility and disposed of as biohazardous waste by a licensed  facility.</p><p class="depth0"><em>(4)</em> Ground transport vehicle cargo compartments must be large enough  to allow safe stowage of NHP crates in a manner that allows ready access  to each NHP during transit without unloading any crates.</p><p class="depth0"><em>(5)</em> After transport of the NHP shipment from the port of entry to  the quarantine facility, the importer must notify HHS/CDC in writing,  text message, or email as specified within the SOP, within 48 hours of  the time the shipment arrived at the quarantine facility.</p><p class="depth0"><em>(6)</em> As part of the notification of arrival in paragraph (k)(5) of  this section, an importer must inform HHS/CDC whether suspected or  confirmed transmission or spread of communicable disease occurred during  transport, including notification of NHPs that died, became ill, or were  injured during transport, or malfunctions associated with disease- mitigation procedures or equipment.</p><p class="depth0"><em>(l)</em> Quarantine facilities. </p><p class="depth0"><em>(1)</em> The requirements of this paragraph  (l) relating to quarantine facilities do not apply to laboratory-to- laboratory transfers or zoo-to-zoo transfers that are in compliance with  paragraphs (p)(2) and (q)(2) of this section, respectively.</p><p class="depth0"><em>(2)</em> An importer must maintain a quarantine facility for holding a  cohort during the required quarantine period. NHPs must be quarantined  for 31 days after arrival at the importer's quarantine facility. HHS/CDC  may extend the quarantine period if an importer or HHS/CDC finds or  suspects that an NHP is infected with, or has been exposed to, a  zoonotic disease, or if an importer or HHS/CDC finds a need for  additional diagnostic testing.</p><p class="depth0"><em>(i)</em> For any quarantine facility established or maintained under this  section, an importer must establish, implement, maintain, and adhere to  SOPs that meet the following physical security requirements:</p><p class="depth0"><em>(A)</em> The facility must be locked and secure, with access limited to  authorized, trained, and knowledgeable personnel.</p><p class="depth0"><em>(B)</em> An importer must limit access to NHP quarantine areas to  authorized personnel who are responsible for the transport, study, care,  or treatment of the NHPs.</p><p class="depth0"><em>(ii)</em> An importer must keep the number of workers involved in the  care, transport, and inspection of NHPs to the minimum necessary to  perform these functions.</p><p class="depth0"><em>(iii)</em> The facility must be designed and operated in such a manner as  to allow for adequate disinfecting.</p><p class="depth0"><em>(iv)</em> The facility must have adequate equipment and space for  discarding and disinfecting all equipment, clothing, and caging.</p><p class="depth0"><em>(v)</em> Each heating ventilation and air-conditioning unit in the  quarantine facility must be designed so that there is no mixing of air  among quarantine rooms and each quarantine room must remain under  negative air pressure in   relationship to the common hallway or anteroom(s) adjacent to the  quarantine room.</p><p class="depth0"><em>(vi)</em> Each quarantine room must have air flow indicators (pressure  gauges or visual flow indicators) that are affixed outside the  quarantine room that indicate the direction of airflow into or out of  quarantine rooms and adjoining common hallways and anterooms.</p><p class="depth0"><em>(3)</em> An importer must establish, implement, maintain, and adhere to  SOPs for handling, monitoring, and testing NHPs in quarantine that meet  the following requirements:</p><p class="depth0"><em>(i)</em> An importer must ensure that all NHPs are identified  individually with a unique number or alphanumeric code permanently  applied to the NHP by tattoo, microchip, or other permanent identifier  before importation or after the 31-day quarantine. Tattoos, microchips,  or other permanent identifiers must not be applied during the quarantine  period.</p><p class="depth0"><em>(ii)</em> Health certificates, shipping documents, and NHP health records  must include the number or code required in paragraph (l)(3)(i) of this  section, as well as the age, sex, and species of the NHP.</p><p class="depth0"><em>(iii)</em> An importer must ensure NHPs are confined in a squeeze-back  cage whenever possible and that any individual NHP is anesthetized,  tranquilized, or otherwise restrained before handling.</p><p class="depth0"><em>(iv)</em> A description of handling and transporting samples. For any  procedure involving the use of a syringe, a separate, disposable needle  and syringe must be used, including a sterile needle and syringe for  withdrawing medication from any multi-dose vials (e.g., ketamine).</p><p class="depth0"><em>(v)</em> Before any contaminated item is removed from a quarantine  facility, an importer must ensure that all NHP waste, bedding, uneaten  food, or other possibly contaminated items are disinfected, autoclaved,  or double-bagged for disposal as biomedical waste by a licensed  facility.</p><p class="depth0"><em>(vi)</em> All cages, feeding bottles, reusable items, and other  contaminated items must be disinfected between uses and before disposal.</p><p class="depth0"><em>(vii)</em> Any equipment used for infusion of NHPs must be autoclaved or  incinerated, as appropriate.</p><p class="depth0"><em>(viii)</em> During the quarantine period, an importer must monitor NHPs  for signs of any zoonotic illness, including signs consistent with  yellow fever, monkeypox, or filovirus disease.</p><p class="depth0"><em>(A)</em> If any NHP appears ill during quarantine, an importer must  monitor that NHP for signs of zoonotic illness, including filovirus  disease, and ensure appropriate treatment.</p><p class="depth0"><em>(B)</em> If an Old World NHP displays signs suggestive of filovirus  infection (e.g., diarrhea with melena or frank blood, bleeding from  external orifices or petechiae, or suffusive hemorrhage), and survives,  an importer must collect serum samples on day 31 of quarantine and test  these samples for antibodies to filovirus while the entire cohort  remains in quarantine. An importer must test the serum for  immunoglobulin G (IgG) antibodies to filovirus by using an ELISA  methodology, or other method approved by HHS/CDC.</p><p class="depth0"><em>(C)</em> An importer must not knowingly request a release from HHS/CDC of  any ill NHP from quarantine under paragraph (l)(4) of this section.</p><p class="depth0"><em>(ix)</em> For each NHP in a quarantine facility, an importer must  administer at least three TSTs on the eyelid using old mammalian  tuberculin (MOT), with at least 2 weeks between tests, before the NHP is  released from import quarantine. TSTs must be read and recorded at 24,  48, and 72 hours, and a grading scale for interpretation of these tests  must be listed in an SOP for TB testing.</p><p class="depth0"><em>(A)</em> An importer must ensure that any cohort with positive or  suspicious TST reaction remains in quarantine and receives at least five  additional TSTs (each administered at least two weeks apart) following  removal of the last affected NHP.</p><p class="depth0"><em>(B)</em> The validity of TB test results may be compromised if during  quarantine an NHP contracts a viral illness, including measles; is  treated with steroids; or is immunized. An importer must document such  occurrence(s) and hold the NHPs until they have recovered from the  illness or are no longer on treatment, and for a recommended time after  recovery (to be determined   in consultation with HHS/CDC, depending on the illness or treatment in  question) before TB tests are performed.</p><p class="depth0"><em>(C)</em> An importer must retain records of all TSTs performed during the  lifetime of each NHP at the facility housing the NHP until the NHP is  transferred to another facility. These records must accompany the NHP  during moves to other facilities.</p><p class="depth0"><em>(x)</em> An importer must ensure that different cohorts of NHPs are  quarantined in separate quarantine rooms.</p><p class="depth0"><em>(A)</em> If mixing of cohorts should occur, an importer must treat the  mixed cohort as a single cohort.</p><p class="depth0"><em>(B)</em> All NHPs within that mixed cohort must remain in quarantine  until each NHP in that mixed cohort has completed the minimum 31-day  quarantine period.</p><p class="depth0"><em>(C)</em> Quarantined NHPs must be housed in such a manner that they do  not expose non-quarantined NHPs to non-filtered air and other  potentially infectious materials, including soiled bedding, caging, and  other potentially contaminated items.</p><p class="depth0"><em>(4)</em> Before releasing a NHP from quarantine, an importer must obtain  written permission from HHS/CDC. HHS/CDC may permit the release of a  cohort from quarantine when all the following conditions have been met:</p><p class="depth0"><em>(i)</em> The 31-day quarantine period, including any required extension  of quarantine, has been completed.</p><p class="depth0"><em>(ii)</em> HHS/CDC has confirmed receipt of written notification of the  health status of the NHPs in the shipment from the quarantine facility's  licensed veterinarian as required by paragraph (m)(4) of this section.</p><p class="depth0"><em>(iii)</em> HHS/CDC confirms that the importer has addressed and resolved  to HHS/CDC's satisfaction any NHP or worker communicable disease issues  that were reported to HHS/CDC during shipment.</p><p class="depth0"><em>(5)</em> If HHS/CDC notifies an importer of any evidence that NHPs have  been exposed to a zoonotic disease, the importer must, at the importer's  expense, implement or cooperate in the HHS/CDC's implementation of  additional measures to rule out the spread of suspected zoonotic disease  before releasing a shipment from quarantine, including examination,  additional diagnostic procedures, treatment, detention, isolation,  seizure, or destruction of exposed animals.</p><p class="depth0"><em>(6)</em> An importer must establish, implement, and adhere to SOPs for  safe handling and necropsy of any NHP that dies in quarantine. The SOPs  must ensure the following:</p><p class="depth0"><em>(i)</em> The carcass of the NHP must be placed in a waterproof double-bag  and properly stored for necropsy, specimen collection, autoclaving and/ or incineration, and disposal;</p><p class="depth0"><em>(ii)</em> A necropsy must be performed by a veterinary pathologist or  state-licensed veterinarian. Each necropsy report must address all major  organ systems and incorporate clinical history and laboratory findings;</p><p class="depth0"><em>(iii)</em> Necropsy and appropriate laboratory testing of the NHP must  document the cause of death and/or rule out zoonotic illness;</p><p class="depth0"><em>(iv)</em> Necropsy must be performed under biosafety level 3 (BSL3) or  enhanced biosafety level 2 ``plus'' (BSL2 + ) to protect against  exposure to highly infectious agents;</p><p class="depth0"><em>(v)</em> Any samples of tissues, blood, serum, and/or transudates (bodily  fluid) collected during necropsy must be retained until the NHP shipment  has been released from quarantine by HHS/CDC, in case other testing is  required by HHS/CDC;</p><p class="depth0"><em>(vi)</em> Fresh and formalin-fixed tissue specimens, including  tracheobronchial lymph node, liver, lung, and spleen, regardless of  necropsy findings, must be collected for laboratory examination;</p><p class="depth0"><em>(vii)</em> Any granulomatous lesions found in any NHP at necropsy,  regardless of whether TB in the NHP was previously suspected, must be  submitted to a laboratory for laboratory examination for acid-fast  bacilli and for mycobacterial culture; and</p><p class="depth0"><em>(viii)</em> In the event that an Old World NHP dies or is euthanized for  any reason other than trauma or unexpected adverse environmental  conditions during quarantine, liver tissue for filovirus antigen by  using the antigen-capture ELISA method must be submitted to a qualified  laboratory for testing. The laboratory should provide documentation of  test validation and records of ongoing quality assurance.</p><p class="depth0"><em>(m)</em> Health reporting requirements for nonhuman primates. </p><p class="depth0"><em>(1)</em> An  importer must notify HHS/CDC of the events listed in this paragraph (m)  by telephone, text, or email.</p><p class="depth0"><em>(2)</em> An importer must notify HHS/CDC within 24 hours of the  occurrence of any morbidity or mortality of NHPs in quarantine  facilities, or following a zoo-to-zoo or laboratory-to-laboratory  transfer.</p><p class="depth0"><em>(3)</em> For any morbidity or mortality from time of embarkation from  country of origin to release from HHS/CDC quarantine, an importer must  report the circumstances to HHS/CDC promptly, including the cause of  death for each NHP.</p><p class="depth0"><em>(4)</em> Upon completion of the quarantine period and before an importer  releases any NHP, cohort, or mixed cohort from quarantine, the importer  must ensure that the quarantine facility's licensed veterinarian  notifies HHS/CDC in writing of the health status of the shipment.</p><p class="depth0"><em>(5)</em> An importer must notify HHS/CDC within 24 hours if any NHP tests  positive for filovirus virus antigen or antibody.</p><p class="depth0"><em>(6)</em> An importer must report to HHS/CDC within 24 hours, any positive  or suspicious TST results, necropsy findings, or laboratory results. Any  report required under this section must include a copy or summary of the  individual NHP's health records.</p><p class="depth0"><em>(n)</em> Recordkeeping and reporting requirements for importing NHPs. </p><p class="depth0"><em>(1)</em>  Before authorizing the import of any NHPs, an importer must be in  compliance with all applicable elements of the importer's SOPs.</p><p class="depth0"><em>(2)</em> At least seven days before importing a shipment of NHPs, an  importer must notify HHS/CDC in writing or by email of the impending  shipment and provide the following information:</p><p class="depth0"><em>(i)</em> The importer's name and address;</p><p class="depth0"><em>(ii)</em> Number and species of NHPs being imported;</p><p class="depth0"><em>(iii)</em> Description of crates;</p><p class="depth0"><em>(iv)</em> Means of individually identifying NHPs;</p><p class="depth0"><em>(v)</em> Origin of NHPs, including the country, the exporter, and the  exporter's address;</p><p class="depth0"><em>(vi)</em> Use of NHPs under paragraph (h) of this section;</p><p class="depth0"><em>(vii)</em> Specific itinerary with names, dates, flights, times,  airports, sea ports, and responsible parties to contact at every step of  travel, including all ground transportation;</p><p class="depth0"><em>(viii)</em> Port of entry;</p><p class="depth0"><em>(ix)</em> If arriving by flight, the name of the airline and its flight  number;</p><p class="depth0"><em>(x)</em> If arriving by vehicle, the name of the vehicle's owner and its  license plate number;</p><p class="depth0"><em>(xi)</em> If arriving by ship, the name of the ship and its vessel  number;</p><p class="depth0"><em>(xii)</em> Name and address of the destination quarantine facility;</p><p class="depth0"><em>(xiii)</em> Name, address, and contact information for shipper, if other  than the importer;</p><p class="depth0"><em>(xiv)</em> If applicable, name, address, and contact information for  broker in the United States;</p><p class="depth0"><em>(xv)</em> Name, address, and contact information for the person(s)  responsible for off-loading NHPs in the United States;</p><p class="depth0"><em>(xvi)</em> Name, address, and contact information for any party  responsible for ground transportation from port of entry to quarantine  facility;</p><p class="depth0"><em>(xvii)</em> Expected quarantine facility, if different from the importer;</p><p class="depth0"><em>(xviii)</em> Master air waybill number for shipment;</p><p class="depth0"><em>(xix)</em> CITES permit number and expiration date.</p><p class="depth0"><em>(o)</em> Animal acts. </p><p class="depth0"><em>(1)</em> All animal acts must be registered with HHS/CDC  under paragraph (g) of this section. In addition to the requirements in  paragraph (g) of this section, which incorporates the requirements in  paragraphs (h) through (m), an importer must provide:</p><p class="depth0"><em>(i)</em> A description of the animal act that includes each NHP.</p><p class="depth0"><em>(ii)</em> Brochures, advertising materials, and/or documentation of  recent or planned animal act performances.</p><p class="depth0"><em>(iii)</em> A current list of all NHPs in the animal act, indicating each  NHP's name, species, sex, age, distinguishing physical description, and  unique identifier such as a tattoo, microchip, or other permanent  identifier.</p><p class="depth0"><em>(iv)</em> Prior to entry or re-entry into the United States, specific  itinerary with names, dates, flights, times, airports, sea ports, and  responsible parties   to contact at every step of travel, including all ground transportation.</p><p class="depth0"><em>(v)</em> A description, diagram, and photographs of the facilities where  the importer houses the NHPs in the animal act in the United States,  including illustrations of the primate caging and/or enclosures; the  relationship of these cages or enclosures to other structures on the  property and adjoining properties; whether the primate facilities are  open to the air or fully enclosed; and the physical security measures of  the facility.</p><p class="depth0"><em>(vi)</em> Documentation signed by a licensed veterinarian describing the  physical exam performed on each NHP in the animal act. Such examinations  must be performed at least once a year. The physical exam must include  the following:</p><p class="depth0"><em>(A)</em> Routine complete blood counts, clinical chemistries, fecal  exams, and any additional testing indicated by the physical exam.</p><p class="depth0"><em>(B)</em> At least once a year, TB testing with MOT and interpreted as  stated in paragraph (l)(3)(ix) of this section;</p><p class="depth0"><em>(C)</em> NHPs with positive TST results must be evaluated for potential  antituberculosis chemotherapy in consultation with HHS/CDC.</p><p class="depth0"><em>(D)</em> If the NHP is a chimpanzee, serology and antigen testing for  hepatitis B, serology for hepatitis C, and any additional titers must be  performed as indicated by clinical history or exam. A chimpanzee found  serologically positive for hepatitis B and/or hepatitis C is ineligible  for entry or re-entry into the United States, unless confirmatory  evidence signed by a licensed veterinarian shows that there is no  hepatitis B or hepatitis C virus present in the NHP.</p><p class="depth0"><em>(vii)</em> SOPs for transporting the NHPs internationally, including the  shipping crates or enclosures, the type of conveyance, and measures to  minimize human exposure to the NHPs.</p><p class="depth0"><em>(viii)</em> A copy of a negative TST conducted within the past 12 months,  or medical documentation that the individual is free of clinically  active TB, for each trainer and/or handler.</p><p class="depth0"><em>(ix)</em> A copy of each SOP for responding to suspected zoonotic  diseases.</p><p class="depth0"><em>(x)</em> If macaques are in the animal act, an SOP for responding to  potential herpes B-virus exposures.</p><p class="depth0"><em>(p)</em> Zoo-to-zoo transfers. (1) Persons who will only be importing  live NHPs into the United States through transfer from one zoo to  another must comply with all the elements listed in paragraphs (g), (h),  (n), (i)(1) through (5), (i)(6)(i), (i)(6)(v), (i)(6)(vi), (i)(7)  through (9); (j)(1), (j)(2), (j)(5), (j)(10) through (12); (k)(5) and  (k)(6); and (m)</p><p class="depth0"><em>(1)</em>, (m)(2), (m)(5), and (m)(6) of this section.</p><p class="depth0"><em>(2)</em> If a zoo is importing one or more NHPs into the United States  from another zoo, the recipient zoo must, before the transfer, submit  the following information for approval by HHS/CDC:</p><p class="depth0"><em>(i)</em> A copy of each NHP's veterinary medical records, including  regular testing for TB from the previous zoo for HHS/CDC's approval. The  medical record should include a positive identification of the NHP, such  as a tattoo, microchip, or photograph.</p><p class="depth0"><em>(ii)</em> A copy of a current health certificate, including documentation  of a negative TB test, signed by a state licensed veterinarian within 14  days of the transfer stating that the NHP(s) appear healthy and are free  from communicable diseases; and</p><p class="depth0"><em>(iii)</em> Documentation which verifies that the recipient zoo is  registered in accordance with this section, and</p><p class="depth0"><em>(iv)</em> A specific itinerary with names, dates, flights, times,  airports, seaports, and responsible parties to contact at every step of  travel, including all ground transportation.</p><p class="depth0"><em>(3)</em> Persons importing live NHPs that are transferred from one zoo to  another, who are not able to meet the requirements listed in paragraphs  (p)(2)(i) and (ii) of this section, must comply with all the elements in  paragraphs (g), (h), (i), (j), (k), (l), (m), and (n) of this section.</p><p class="depth0"><em>(q)</em> Laboratory-to-laboratory transfers. (1) A laboratory  transferring NHPs on an established research protocol from its foreign- based facility to its U.S.-based laboratory must comply with all the  elements listed in paragraphs (g), (h), (i), (j), (k), and (n) of this  section; and paragraphs (m)</p><p class="depth0"><em>(1)</em>, (m)(2), (m)(5), and (m)(6) of this  section.</p><p class="depth0"><em>(2)</em> If a lab is receiving one or more NHPs for purposes related to  an ongoing research project from another established research facility  outside the United States, the recipient facility must, before the  transfer, submit the following to HHS/CDC for approval:</p><p class="depth0"><em>(i)</em> A copy of each NHP's veterinary medical records, including  regular testing for TB from the previous lab for HHS/CDC's approval. The  medical record should include a positive identification of the NHP, such  as a tattoo, microchip, or photograph.</p><p class="depth0"><em>(ii)</em> A copy of a current health certificate(s), including  documentation of a negative TST, signed by a state-licensed veterinarian  within 14 days of the transfer stating that the NHP(s) appear healthy  and are free from communicable diseases; and</p><p class="depth0"><em>(iii)</em> Documentation of the ongoing IACUC-approved research project  and the reason the NHP needs to be transported to the U.S. laboratory  facility.</p><p class="depth0"><em>(iv)</em> A specific itinerary with names, dates, flights, times,  airports, seaports, and responsible parties to contact at every step of  travel, including all ground transportation.</p><p class="depth0"><em>(3)</em> Persons importing live NHPs that are transferred from one lab to  another, who are not able to meet the requirements listed in paragraphs  (q)(2)(i), (ii), and (iii) of this section, must comply with all the  elements in paragraphs (g), (h), (i), (j), (k), (l), (m), and (n) of  this section.</p><p class="depth0"><em>(r)</em> In transit shipments of NHPs. </p><p class="depth0"><em>(1)</em> Before arrival into the United  States, brokers of in transit shipments must notify HHS/CDC of all  scheduled in transit shipments of NHPs not intended for import into the  United States and provide the following information:</p><p class="depth0"><em>(i)</em> Number and species of NHPs in the shipment;</p><p class="depth0"><em>(ii)</em> Origin of NHPs, including the country, the exporter, and the  exporter's address;</p><p class="depth0"><em>(iii)</em> Name and full address of the final destination quarantine  facility in the importing country;</p><p class="depth0"><em>(iv)</em> Means of individually identifying NHPs, if required by the  importing country;</p><p class="depth0"><em>(v)</em> A specific itinerary while in the United States including names,  dates, flights, times, airports, seaports, and responsible parties to  contact at every step of travel within the United States, including all  ground transportation;</p><p class="depth0"><em>(vi)</em> Description of crates;</p><p class="depth0"><em>(vii)</em> SOPs describing procedures to protect and train transport  workers from exposure to communicable disease while handling NHPs;</p><p class="depth0"><em>(viii)</em> SOPs describing procedures to prevent contamination of other  articles and cargo during transit, including physical separation of  crates from other cargo;</p><p class="depth0"><em>(ix)</em> SOPs describing procedures to decontaminate aircraft, ships,  vehicles, and related equipment following transport; and</p><p class="depth0"><em>(x)</em> Proposed use, if any, of in transit holding facilities and steps  to be taken to protect workers, as well as NHPs, from communicable  disease exposure at each facility to be used en route.</p><p class="depth0"><em>(2)</em> While located in the United States, in transit shipments must be  housed and cared for in a manner consistent with requirements for NHPs  intended for import into the United States as specified in paragraphs  (j) and (k) of this section.</p><p class="depth0"><em>(s)</em> Revocation and reinstatement of an importer's registration. </p><p class="depth0"><em>(1)</em>  If the Director determines that an importer has failed to comply with  any applicable provisions of this section, including the importer's  SOPs, the Director may revoke the importer's registration.</p><p class="depth0"><em>(2)</em> HHS/CDC will send the importer a notice of revocation stating  the grounds upon which the proposed revocation is based.</p><p class="depth0"><em>(i)</em> If the importer wishes to contest the revocation, the importer  must file a written response to the notice within 20 calendar days after  receiving the notice.</p><p class="depth0"><em>(A)</em> As part of the response, an importer may request that the  Director review the written record.</p><p class="depth0"><em>(B)</em> If an importer fails to file a response within 20 calendar days,  all of the grounds listed in the proposed revocation will be deemed  admitted, in which case the notice shall constitute final agency action.</p><p class="depth0"><em>(ii)</em> [Reserved]</p><p class="depth0"><em>(3)</em> If an importer's response is timely, the Director will review  the registration, the notice of revocation, and   the response, and make a decision in writing based on the written  record.</p><p class="depth0"><em>(4)</em> As soon as practicable after completing the written record  review, the Director will issue a decision in writing that shall  constitute final agency action. The Director will serve the importer  with a copy of the written decision.</p><p class="depth0"><em>(5)</em> The Director may reinstate a revoked registration after  inspecting the importer's facility, examining its records, conferring  with the importer, and receiving information and assurance from the  importer of compliance with the requirements of this section.</p><p class="depth0"><em>(t)</em> Nonhuman primate products. </p><p class="depth0"><em>(1)</em> NHP products may be imported  without obtaining a permit under this section if accompanied by  documentation demonstrating that the products have been rendered  noninfectious using one of the following methods:</p><p class="depth0"><em>(i)</em> Boiling in water for an appropriate time so as to ensure that  any matter other than bone, horns, hooves, claws, antlers, or teeth is  removed; or</p><p class="depth0"><em>(ii)</em> Gamma irradiation at a dose of at least 20 kilo Gray at room  temperature (20 [deg]C or higher); or</p><p class="depth0"><em>(iii)</em> Soaking, with agitation, in a 4% (w/v) solution of washing  soda (sodium carbonate, Na2CO3) maintained at pH  11.5 or above for at least 48 hours; or</p><p class="depth0"><em>(iv)</em> Soaking, with agitation, in a formic acid solution (100 kg salt  [NaCl] and 12 kg formic acid per 1,000 liters water) maintained at below  pH 3.0 for at least 48 hours; wetting and dressing agents may be added;</p><p class="depth0"><em>(v)</em> In the case of raw hides, salting for at least 28 days with sea  salt containing 2% washing soda (sodium carbonate,  Na2CO3);</p><p class="depth0"><em>(vi)</em> Formalin fixation; or</p><p class="depth0"><em>(vii)</em> Another method approved by HHS/CDC.</p><p class="depth0"><em>(viii)</em> Fully taxidermied products are considered rendered  noninfectious, and so do not require a permit from the Director.</p><p class="depth0"><em>(2)</em> NHP products that have not been rendered noninfectious are  considered to pose a potential human health risk and may only be  imported under the following circumstances:</p><p class="depth0"><em>(i)</em> The product must be accompanied by a permit issued by the  Director. Requests for permits should be accompanied by an explanation  of the product's intended use and a description of how the product will  be handled to ensure that it does not pose a zoonotic disease threat to  humans. The Director will review the request for a permit, and  accompanying materials, and issue a decision that shall constitute final  agency action.</p><p class="depth0"><em>(ii)</em> The product may only be imported for bona fide scientific,  educational, or exhibition purposes.</p><p class="depth0"><em>(iii)</em> A permit will only be issued if the product will be received  by a facility equipped to handle potentially infectious NHP materials.</p><p class="depth0"><em>(iv)</em> The product must comply with any other applicable federal  requirements, including those relating to packaging, shipping, and  transport of potentially infectious, biohazardous substances as well as  those for select agents pursuant to 42 CFR part 73, 7 CFR part 331, and  9 CFR part 121.</p><p class="depth0"><em>(u)</em> Appeal of denial for a permit to import. If the HHS/CDC denies  your request for a permit under this section, you may appeal that denial  to the HHS/CDC Director.</p><p class="depth0"><em>(1)</em> You must submit your appeal in writing to the HHS/CDC Director,  stating the reasons for the appeal and demonstrating that there is a  genuine and substantial issue of fact in dispute.</p><p class="depth0"><em>(2)</em> You must submit the appeal within 5 business days after you  receive the denial.</p><p class="depth0"><em>(3)</em> HHS/CDC will issue a written response to the appeal, which shall  constitute final Agency action.</p><p class="depth0"><em>(v)</em> Filovirus testing fee. </p><p class="depth0"><em>(1)</em> Non-human primate importers shall be  charged a fee for filovirus testing of non-human primate liver samples  submitted to the Centers for Disease Control and Prevention (CDC).</p><p class="depth0"><em>(2)</em> The fee shall be based on the cost of reagents and other  materials necessary to perform the testing; the use of the laboratory  testing facility; irradiation for inactivation of the sample; personnel  costs associated with performance of the laboratory tests; and  administrative costs for test planning, review of assay results, and  dissemination of test results.</p><p class="depth0"><em>(3)</em> An up-to-date fee schedule is available from the Division of  Global Migration & Quarantine, Centers for   Disease Control and Prevention, 1600 Clifton Road, Atlanta, Georgia  30333. Any changes in the fee schedule will be published in the Federal  Register.</p><p class="depth0"><em>(4)</em> The fee must be paid in U.S. dollars at the time that the  importer submits the specimens to HHS/CDC for testing.  [78 FR 11538, Feb. 15, 2013]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with  by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
